Literature DB >> 3254111

An intra-erythrocytic low molecular weight lead-binding protein in acute and chronic lead exposure and its possible protective role in lead toxicity.

Y Lolin1, P O'Gorman.   

Abstract

A low-molecular-weight protein was measured in erythrocytes from workers with chronic and recent lead exposure, with and without clinical lead toxicity, and from a group of control subjects not exposed to undue environmental lead. The protein was detected in all the workers, but in significantly smaller amounts in those with symptoms, and was absent from controls. The synthesis of the protein is induced at blood lead concentrations above 1.9 mumol/L, but is reduced in workers susceptible to clinical lead toxicity at blood lead concentrations below 4.0 mumol/L. The activity of the red blood cell dithiothreitol (DTT)--activated 5-aminolaevulinate dehydratase (ALA-D) was correlated with the concentration of the low-molecular-weight protein, with both being particularly low in the symptomatic workers. Previous studies have shown that the protein binds lead. By sequestrating excess lead into a non-toxic form, the protein may have a protective role in preventing clinical, and reducing biochemical, lead toxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3254111     DOI: 10.1177/000456328802500616

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  6 in total

1.  Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls.

Authors:  A Schütz; I A Bergdahl; A Ekholm; S Skerfving
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

2.  delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.

Authors:  B S Schwartz; B K Lee; W Stewart; P Sithisarankul; P T Strickland; K D Ahn; K Kelsey
Journal:  Occup Environ Med       Date:  1997-04       Impact factor: 4.402

3.  Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak.

Authors:  A Pagliuca; G J Mufti; D Baldwin; A N Lestas; R M Wallis; A J Bellingham
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

4.  Lead-binding proteins: a review.

Authors:  Harvey C Gonick
Journal:  J Toxicol       Date:  2011-09-19

Review 5.  Roles of lead-binding proteins in mediating lead bioavailability.

Authors:  B A Fowler
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

6.  A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead.

Authors:  C M Smith; X Wang; H Hu; K T Kelsey
Journal:  Environ Health Perspect       Date:  1995-03       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.